Results 81 to 90 of about 4,350 (187)

Significant improvement of refractory cutaneous lesions of lupus erythematosus with the use of anifrolumab: a report of two cases

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
Anifrolumab, a monoclonal antibody targeting the interferon-1 receptor, is currently approved for the treatment of moderate- to-severe systemic lupus erythematosus, but emerging evidence highlights its potential efficacy in cases with predominant ...
Gilberto P. da Rosa, Isabel Antunes, Bárbara V. Granja, Patrícia Gomes, Rúben Costa, Filomena Azevedo, Alberto Mota   +6 more
doaj  

Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study

Mediators of Inflammation, 2016
We compared the presence of diverse cytokines and regulatory T and B cells in skin biopsies of discoid lupus erythematosus (DLE) and subacute cutaneous lupus erythematosus (SCLE).
Silvia Méndez-Flores, Gabriela Hernández-Molina, Ana Bety Enríquez, David Faz-Muñoz, Yeraldin Esquivel, Carlos Pacheco-Molina, Janette Furuzawa-Carballeda   +6 more
doaj   +1 more source

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series

, 2021
Emily Keyes, Madison Grinnell, Thomas Vazquez, DeAnna Diaz, Preethi Thomas, Victoria P. Werth   +5 more
openalex   +1 more source

Lansoprazole-Induced Subacute Cutaneous Lupus Erythematosus

Archives of Rheumatology, 2017
A 23-year-old female patient presented with a one-week history of itchy skin lesions distributed on the upper chest, extensor sides of the arms, and the trunk. Two weeks earlier, the patient had been prescribed lansoprazole 40 mg/day due to the symptoms of gastroesophageal reflux.
An, Isa, Demir, Vasfiye, Ibiloglu, Ibrahim, Akdeniz, Sedat, Ucmak, Derya   +4 more
openaire   +2 more sources

Terbinafine-induced subacute cutaneous lupus erythematosus in two patients with systemic lupus erythematosus successfully treated with topical corticosteroids [PDF]

, 2013
Agnieszka Kalińska‐Bienias, Cezary Kowaléwski, Katarzyna Woźniak   +2 more
openalex   +1 more source

Drug-induced lupus erythematosus

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2023
Drug-induced lupus erythematosus is an autoimmune disease with unexpected onset after treatment with certain drugs. Clinically, this disease is very similar to idiopathic lupus erythematosus, although its manifestations are typically milder. In addition,
Ana L. Gouveia, Margarida Gonçalo
doaj  

Etanercept‐induced subacute cutaneous lupus erythematosus [PDF]

, 2001
G. S. Bleumink, E. J. ter Borg, C.G. Ramselaar, B. H. Ch. Stricker   +3 more
openalex   +1 more source

Leflunomide a rare culprit for drug induced subacute cutaneous lupus erythematosus [PDF]

, 2020
M N Mahesha, B Prashanthi, T. Dinupa, Niranthi Perera   +3 more
openalex   +1 more source

[Subacute cutaneous lupus erythematosus].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1997
Subacute cutaneous lupus erythematosus (SCLE) is recognized as a variant of Systemic lupus erythematosus (SLE) and affects mainly middle-aged Caucasian women. The clinical picture is characterized by typical skin lesions, joint or muscle pain and occasionally arthritis. Serious systemic manifestations such as affection of the central nervous system and
S, Jore, J T, Gran
openaire   +1 more source

Propofol Induced Subacute Cutaneous Lupus Erythematosus: A Case Report. [PDF]

A A Pract, 2023
Schoenfeldt JA, Howard MA, Masood D, Cormican DS.   +3 more
europepmc   +1 more source